Associate Director, Field Medical & Access Platform Strategy at Bristol-Myers Squibb

Princeton, New Jersey, United States

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

  • Bachelor's degree
  • 7+ years of experience

Responsibilities

  • Drive robust collaboration between Medical, Access, and Field teams by leading change management initiatives and facilitating transparent communication through stakeholder forums, roadmaps, and capability overviews
  • Engage cross-functional stakeholders including US Sales, Medical, MAX teams, Global ITBP’s, WCx, Medical Excellence, to ensure alignment and shared ownership of platform strategy and execution
  • Ensure Medical and Access requirements are proactively incorporated into platform roadmaps and operational models by resetting and communicating end-user expectations, and redefining release and prioritization processes
  • Collaborate with Medical Affairs to align platform capabilities with scientific engagement strategies, ensuring compliance with standards
  • Support Access teams by integrating platform functionalities that facilitate payer and access stakeholder engagement
  • Lead the measurement of platform utilization, adoption, and impact through analytics and insights, supporting continuous improvement and informed decisions on retention or decommissioning of capabilities
  • Partner with BI&T colleagues, and other matrix partners (TAs, Markets, Commercial, Clinical, Procurement, Compliance) to optimize platforms for exceptional user experience and compliance
  • Identify and align on user experience (UX) changes for current and future CRM platforms, leveraging advisory boards and FIT teams to document business requirements and drive platform evolution
  • Maintain translation of business to technical translation ownership for platforms and channels used for Field Medical and Access Engagement with HCPs, ensuring platforms are optimized for usability, compliance, and stakeholder value
  • Serve as a subject matter expert, interfacing globally to understand business needs, educate teams on available capabilities, and drive alignment on strategic direction
  • Manage vendor relationships to influence platform evolution and ensure future roadmaps support business needs
  • Maintain strong partnerships with Field Excellence & Platform Strategy colleagues to ensure consistency in stakeholder messaging and engagement

Skills

CRM
Strategy
Change Management
Stakeholder Engagement
Roadmaps
Operating Models
Cross-Functional Collaboration
Field Medical
Medical Affairs
Access Strategy

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI